15-Nov-2007

New data for Menveo(TM) vaccine show excellent immune response and broad protection for infants against meningococcal meningitis

 

 

19-Oct-2007

Novartis MF59™-adjuvanted influenza vaccine (Fluad) significantly reduces hospitalization in elderly

 

 

23-Aug-2007

Novartis breaks ground on state-of-the-art influenza vaccine manufacturing facility in Holly Springs, North Carolina

 

 

16-Aug-2007

Novartis starts US shipment of Fluvirin allowing for early influenza vaccination of millions of Americans

 

 

03-Jul-2007

Novartis plans 30% increase in US supplies of Fluvirin influenza vaccines and delivery of 40 million doses for 2007/2008 season

 

 

02-Jul-2007

Novartis enhances its vaccine pipeline by gaining access to Intercell's key technologies and vaccines programs

 

 

13-Jun-2007

Novartis gains European approval for its innovative flu vaccine Optaflu

 

 

08-May-2007

Focetria, the Novartis pandemic influenza vaccine, receives European Union approval

 

 

27-Apr-2007

Optaflu, the Novartis cell culture-derived influenza vaccine, receives positive opinion supporting European Union regulatory approval

 

 

23-Feb-2007

Focetria pandemic influenza vaccine receives positive European Union regulatory agency opinion supporting approval

 

 

17-Jan-2007

Novartis receives US government contract to further develop a novel antigen technology that could extend vaccine supplies in a pandemic outbreak